Endometriosis Ovary
15
3
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
The Therapy of Large Endometrioma
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Conservative Endometrioma Surgery
Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma
Menstrual Blood Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study
A Multicenter, Observational Clinical Study of Dydrogesterone
Changes in Serum antimüllerian Hormone Levels in Patients 3 and 12 Months After Endometrioma Sclerotherapy
The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis
Comparison of Operated Ruptured and Non-ruptured Endometriomas
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis
EHP-5 in Preoperative Assessment in Women With Endometriosis
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma
Pretreatment With Dienogest in Women With Endometriosis Undergoing in Vitro-fertilization After a Previous Failed Cycle
Impact on Ovarian Reserve According to the Type of Ovarian Endometrioma Excision: Laser Versus Conventional Cystectomy